Symmetrical peripheral gangrene complicating recurrent cholangiocarcinoma: a case report Authors Chao Yang Department of Critical Care Medicine, The Second Hospital of Traditional Chinese Medicine of Yibin, Yibin, China Jing Hu Department of Critical Care Medicine, The Second Hospital of Traditional Chinese Medicine of Yibin, Yibin, China Xiaoping He Department of Critical Care Medicine, The Second Hospital of Traditional Chinese Medicine of Yibin, Yibin, China Xianming Fan Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, China DOI: https://doi.org/10.47391/JPMA.21093 Keywords: Cholangiocarcinoma, Symmetrical peripheral gangrene, Sepsis, Diffuse intravascular coagulation Abstract Symmetrical peripheral gangrene (SPG) is a rare, life-threatening complication often linked to severe illnesses. This case report describes the case of a 28-year-old male with recurrent cholangiocarcinoma who developed SPG after being admitted to the intensive care unit (ICU) for septic shock. Despite initial survival with antibiotics, vasopressors, and supportive care, he refused amputation, leading to secondary infection and death. Early management of septic shock and disseminated intravascular coagulation (DIC), with cautious vasopressor use, is crucial to prevent SPG. Keywords: Cholangiocarcinoma, Symmetrical peripheral gangrene, Sepsis, Diffuse intravascular coagulation. Downloads Full Text Article Published 2025-07-28 How to Cite Yang, C., Hu, J., He, X., & Fan, X. (2025). Symmetrical peripheral gangrene complicating recurrent cholangiocarcinoma: a case report. Journal of the Pakistan Medical Association, 75(8), 1277–1280. https://doi.org/10.47391/JPMA.21093 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Download Citation Endnote/Zotero/Mendeley (RIS) BibTeX Issue Vol. 75 No. 8 (2025): AUGUST Section CASE REPORT License Copyright (c) 2025 Journal of the Pakistan Medical Association This work is licensed under a Creative Commons Attribution 4.0 International License.